1. Office of National Drug Control Policy. Marijuana Resource Center. State Laws Related to Marijuana. Available at: https://www.whitehouse.gov/ondcp/state-laws-related-to-marijuana . Accessed December 12, 2015.
2. American Academy of Family Physicians. AAFP policies: marijuana. Available at: http://www.aafp.org/about/policies/all/marijuana.html . Accessed January 16, 2016.
3. American College of Physicians. Supporting research into the therapeutic role of marijuana. Available at: https://www.acponline.org/acp_policy/policies/supporting_medmarijuana_2008.pdf . Accessed January 26, 2016.
4. Institute of Medicine. Marijuana and medicine: assessing the science base. Available at: http://iom.nationalacademies.org/reports/1999/marijuana-and-medicine-assessing-the-science-base.aspx . Accessed January 26, 2016.
5. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA . 2015;313:2456-2473.
6. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA . 2015;313:2474-2483.
7. Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo controlled trial. Lancet . 2003;362:1517-1526.
8. Zajicek JP, Hobart JC, Slade A, et al. MUSEC research group. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry . 2012;83:1125–1132.
9. Koppel BS, Brust JCM, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology . 2014;82:1556-1563.
10. Kahan M, Srivastava A, Spithoff S, et al. Smoked CB for chronic noncancer pain. Can Fam Physician . 2014;60:1083–1090.
11. Todaro B. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J Natl Compr Canc Network . 2012;10:487-492.
12. Tramer MR, Carroll D, Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systemic review. BMJ . 2001;323:16-21.
13. Jatoi A, Windschitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol . 2002;20:567-573.
14. Hu SS, Mackie K. Distribution of the endocannabinoid system in the central nervous system. Handbook Exp Pharmacol . 2015;231:59-93.
15. Bhattacharyya S, Morrison PD, Fusar-Poli P. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology . 2010;35:764-774.
16. Hazekamp A, Ware MA, Muller-Vahl KR, et al. The medicinal use of cannabis and cannabinoids – an international cross sectional survey on administration forms. J Psychoactive Drugs . 2013;45:199-210.
17. ProCon.org site. 10 pharmaceutical drugs based on cannabis. Available at: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000883 . Accessed January 28, 2016.
18. Cerda M, Wall M, Keyes KM, et al. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana, abuse and dependence. Drug Alcohol Depend . 2012;120:22-27.
19. US Food and Drug Administration. Inter-agency advisory regarding claims that smoked marijuana is a medicine. April 20, 2006. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108643 . Accessed January 29, 2016.
20. Marinol dronabinol capsules. Available at: www.marinol.com . Accessed January 29, 2016.
21. Cesamet full prescribing information. Available at: http://www.cesamet.com/patient-home.asp . Accessed January 29, 2016.
22. Aoyagi T, Terracini KP, Raza A, et al. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol . 2015;7:17-29.
23. Strasser F, Laftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9 tetrahydrocannabinol (THC) in treating patients with cancer-related anorexia cachexia syndrome, a multicenter, randomized, double blind controlled clinical trial from the Cannabis-In Cachexia Study Group. Clin Oncol . 2006;24:3394 -3400.
24. Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database Syst Rev . 2013;(4):CD005175.
25. Phillips JA, Holland MG, Baldwin DD. Marijuana in the workplace: guidance for occupational health professionals and employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine. J Occup Environ Med . 2015;57:459-475.
26. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Phys . 2012;15:ES67-ES92.
27. Lopez-Quintero C, de los Cabos JP, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend . 2011:115:120-130.
28. Strobbe S. Prevention and screening, brief intervention and referral to treatment for substance use in primary care. Primary Care . 2014;41:185-213.
29. Ehlers CL, Gizer IR, Vieten C, et al. Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Addict Behav . 2010;35:102-110.
30. American Society of Addiction Medicine. Drug testing: a white paper of the American Society of Addiction Medicine. Available at: http://www.asam.org/docs/default-source/publicy-policy-statements/drug-testing-a-white-paper-by-asam.pdf?sfvrsn=2 . October 26, 2013. Accessed January 26, 2016.
31. Tomar RS, Beaumont J, Hsieh JCY. Evidence on the carcinogenicity of marijuana smoke. California EPA: Reproductive and Cancer Hazard Assessment Branch of the Office of Environmental Health Hazard Assessment. August 2009. Available at: http://oehha.ca.gov/prop65/hazard_ident/pdf_zip/FinalMJsmokeHID.pdf . Accessed January 29, 2016.
32. Salomonsen–Sautel S, Sakai JT, Thurstone C. Medical marijuana use among adolescents in substance abuse treatment. J Am Acad Child Adolesc Psychiatry . 2012;7:694-702.
33. Reisfield GM, Goldberger BA, Bertholf RL. ‘False-positive’ and ‘false-negative’ test results in clinical urine drug testing. Bioanalysis . 2009;1:937-952.